Učitavanje...

Effects of Lisdexamfetamine Dimesylate on Functional Impairment Measured on the Sheehan Disability Scale in Adults With Moderate-to-severe Binge Eating Disorder: Results from Two Randomized, Placebo-controlled Trials

Objective: In two Phase III, randomized, placebo-controlled trials (NCT01718483 and NCT01718509 at ClinicalTrials.gov), lisdexamfetamine dimesylate (LDX) reduced binge eating days/week in adults with moderate-to-severe binge eating disorder (BED). We describe the effects of LDX (50mg and 70mg) on th...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Innov Clin Neurosci
Glavni autori: Sheehan, David V., Gasior, Maria, McElroy, Susan L., Radewonuk, Jana, Herman, Barry K., Hudson, James
Format: Artigo
Jezik:Inglês
Izdano: Matrix Medical Communications 2018
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6040726/
https://ncbi.nlm.nih.gov/pubmed/30013816
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!